This was the stock's second consecutive day of losses.

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday’s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Shares of NASDAQ INO opened at $1.98 on Friday. The company has a market capitalization of $51.68 million, a PE ratio of -0.95 and a beta of 0.84. Inovio Pharmaceuticals has a twelve month low of ...

Shares of NASDAQ:INO opened at $1.98 on Friday. The company has a 50-day moving average price of $3.42 and a two-hundred day moving average price of $6.10. Inovio Pharmaceuticals has a twelve ...

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday's session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company with a market capitalization of $51.55 million focused on developing DNA-based immunotherapies for infectious diseases and cancer ...

Shares of Inovio Pharmaceuticals Inc. INO slipped 1.96% to $2.00 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.